DEA schedule
Is sitagliptin a controlled substance?
Federal schedule for sitagliptin from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Sitagliptin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and sitagliptin is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted sitagliptin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 36 prescription listings from 10 labelers, none with a DEA schedule |
| DEA controlled substances list | sitagliptin is not on the list |
Sitagliptin NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 24338-017 | BRYNOVIN | solution | 25 mg/mL | Azurity Pharmaceuticals, Inc. | None |
| 0006-0277 | JANUVIA | tablet, film coated | 100 mg/1 | Merck Sharp & Dohme LLC | None |
| 50090-1036 | JANUVIA | tablet, film coated | 100 mg/1 | A-S Medication Solutions | None |
| 50090-4084 | JANUVIA | tablet, film coated | 100 mg/1 | A-S Medication Solutions | None |
| 55154-5042 | JANUVIA | tablet, film coated | 100 mg/1 | Cardinal Health 107, LLC | None |
| 0006-0221 | JANUVIA | tablet, film coated | 25 mg/1 | Merck Sharp & Dohme LLC | None |
| 50090-3527 | JANUVIA | tablet, film coated | 25 mg/1 | A-S Medication Solutions | None |
| 50090-4087 | JANUVIA | tablet, film coated | 25 mg/1 | A-S Medication Solutions | None |
| 0006-0112 | JANUVIA | tablet, film coated | 50 mg/1 | Merck Sharp & Dohme LLC | None |
| 50090-3472 | JANUVIA | tablet, film coated | 50 mg/1 | A-S Medication Solutions | None |
| 50090-4086 | JANUVIA | tablet, film coated | 50 mg/1 | A-S Medication Solutions | None |
| 55154-5040 | JANUVIA | tablet, film coated | 50 mg/1 | Cardinal Health 107, LLC | None |
| 70710-1242 | ZITUVIO | tablet | 100 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 70771-1772 | ZITUVIO | tablet | 100 mg/1 | Zydus Lifesciences Limited | None |
| 70710-1240 | ZITUVIO | tablet | 25 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 70771-1770 | ZITUVIO | tablet | 25 mg/1 | Zydus Lifesciences Limited | None |
| 70710-1241 | ZITUVIO | tablet | 50 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 70771-1771 | ZITUVIO | tablet | 50 mg/1 | Zydus Lifesciences Limited | None |
| 70710-1901 | Sitagliptin | tablet | 100 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 70771-1792 | Sitagliptin | tablet | 100 mg/1 | Zydus Lifesciences Limited | None |
| 70710-1899 | Sitagliptin | tablet | 25 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 70771-1790 | Sitagliptin | tablet | 25 mg/1 | Zydus Lifesciences Limited | None |
| 70710-1900 | Sitagliptin | tablet | 50 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 70771-1791 | Sitagliptin | tablet | 50 mg/1 | Zydus Lifesciences Limited | None |
| 0480-2609 | Sitagliptin | tablet, film coated | 100 mg/1 | Teva Pharmaceuticals, Inc. | None |
| 60505-3645 | Sitagliptin | tablet, film coated | 100 mg/1 | Apotex Corp. | None |
| 84677-051 | Sitagliptin | tablet, film coated | 100 mg/1 | Golden State Medical Supply, Inc. | None |
| 0480-2607 | Sitagliptin | tablet, film coated | 25 mg/1 | Teva Pharmaceuticals, Inc. | None |
| 60505-3643 | Sitagliptin | tablet, film coated | 25 mg/1 | Apotex Corp. | None |
| 84677-049 | Sitagliptin | tablet, film coated | 25 mg/1 | Golden State Medical Supply, Inc. | None |
| 0480-2608 | Sitagliptin | tablet, film coated | 50 mg/1 | Teva Pharmaceuticals, Inc. | None |
| 60505-3644 | Sitagliptin | tablet, film coated | 50 mg/1 | Apotex Corp. | None |
| 84677-050 | Sitagliptin | tablet, film coated | 50 mg/1 | Golden State Medical Supply, Inc. | None |
| 0781-5770 | Sitagliptin Phosphate | tablet, film coated | 100 mg/1 | Sandoz Inc | None |
| 0781-5766 | Sitagliptin Phosphate | tablet, film coated | 25 mg/1 | Sandoz Inc | None |
| 0781-5768 | Sitagliptin Phosphate | tablet, film coated | 50 mg/1 | Sandoz Inc | None |
Questions
Is sitagliptin a controlled substance?
No. Sitagliptin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and sitagliptin is not on the DEA controlled substances list.
Is sitagliptin a narcotic?
No. Sitagliptin is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Dipeptidyl Peptidase 4 Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Sitagliptin
- What is Sitagliptin used for?FDA label uses
- Generic for JanuviaFDA Orange Book
- Generic for ZituvioFDA Orange Book
- What is Januvia used for?FDA label uses
- Is Januvia a controlled substance?Federal schedule
- Dipeptidyl Peptidase 4 Inhibitors listFDA drug class
- Sitagliptin Medicare Part D coverageBy plan and state
- NDC 0006-0112Sitagliptin NDC record
- NDC 0006-0221Sitagliptin NDC record
- NDC 0006-0277Sitagliptin NDC record